A Study to Evaluate Camrelizumab in Combination With Nb-Paclitaxel in Patients With Advanced or Metastatic NSCLC
Clinical trial NCT04167774 · UNKNOWN
Trial details
- NCT number
- NCT04167774
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-30
- Primary completion
- 2022-06-30
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.